A detailed history of Intech Investment Management LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 26,676 shares of ANNX stock, worth $76,293. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,676
Previous 52,699 49.38%
Holding current value
$76,293
Previous $126,000 37.3%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$2.05 - $3.37 $53,347 - $87,697
-26,023 Reduced 49.38%
26,676 $79,000
Q2 2025

Aug 08, 2025

SELL
$1.38 - $2.73 $20,101 - $39,765
-14,566 Reduced 21.65%
52,699 $126,000
Q1 2025

May 20, 2025

BUY
$1.93 - $5.5 $41,570 - $118,464
21,539 Added 47.1%
67,265 $129,000
Q4 2024

Feb 10, 2025

BUY
$4.44 - $7.63 $87,525 - $150,410
19,713 Added 75.78%
45,726 $234,000
Q3 2024

Nov 08, 2024

BUY
$4.49 - $7.2 $116,798 - $187,293
26,013 New
26,013 $153,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $136M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.